Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Orlistat Market Valuation Change Between Now And 2029?

The size of the orlistat market has displayed significant growth in the past few years. The market is projected to expand from $3.03 billion in 2024 to $3.2 billion in 2025, maintaining a compound annual growth rate (CAGR) of 5.7%. The elevated growth during the previous period can be traced back to increasing cognizance of health hazards tied to obesity, the sanctioning of orlistat as a prescription drug, the easy availability of orlistat over-the-counter in smaller doses, recommendations for its use by physicians, and the skyrocketing costs of healthcare related to obesity.

There’s predicted significant expansion in the orlistat market in the coming years, with its value expected to reach $4.07 billion by 2029, reflecting a Compound Annual Growth Rate (CAGR) of 6.1%. This growth over the forecast period is largely due to factors such as increased healthcare expenditure on obesity treatments, the prevalence of sedentary lifestyles combined with unhealthy diets, governmental initiatives advocating weight loss and healthier lifestyles, an aging demographic, and the move from prescription to over-the-counter options. Looking towards the forecast period, prominent trends include the development of AI-optimised diet plans, the use of telehealth services, automated medical devices that prompt patients to take their medications whilst also monitoring compliance, the emergence of virtual reality-based workouts, and the application of digital therapeutics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18422&type=smp

What Underlying Factors Are Supporting The Orlistat Market Growth?

The upsurge in obesity rates is anticipated to boost the development of the orlistat market. Clinical obesity can be described as an excessive buildup of body fat that has detrimental effects on health and is typically defined by a body mass index (BMI) exceeding 30. Sedentary behavior, inadequate diet, and lack of exercise are among the factors contributing to the rise in obesity. Orlistat serves a crucial role in managing obesity by preventing the absorption of dietary fats, contributing to weight reduction and sustainability of weight loss. Doctors frequently prescribe it in conjunction with a low-calorie diet and regular exercise for amplified results. For instance, in March 2022, data from the World Health Organization (WHO), headquartered in Switzerland, estimated that over 1 billion people worldwide were affected by obesity, which included 650 million adults, 340 million teenagers, and 39 million children. This statistic is continually swelling, with predictions suggesting that by 2025 nearly 167 million individuals, both adults and children inclusive, will experience health complications due to being overweight or obese. This increasing obesity rate, therefore, is fueling the growth of the orlistat market.

Which Sub-Segments Are Driving Growth Within The Orlistat Market?

The orlistatmarket covered in this report is segmented –

1) By Type: 120 Milligram (Mg); 60 Milligram(Mg)

2) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies

3) By Application: Weight-Reducing Aid; Other Applications

Subsegments:

1) By 120 Milligram (Mg): Prescription-Based 120 Mg Orlistat; Over-The-Counter (OTC) 120 Mg Orlistat

2) By 60 Milligram (Mg): Over-The-Counter (OTC) 60 Mg Orlistat; Prescription-Based 60 Mg Orlistat

What Future-Focused Trends Are Anticipated In The Orlistat Market?

Leading corporations in the orlistat industry are capitalizing on innovation, creating products such as weight loss medicine to improve personal cleanliness and comfort through sophisticated technology and architecture. Weight loss medicine is intended to aid people in shedding weight by curbing their appetite, accelerating their metabolism, or preventing fat absorption. Eli Lilly and Company, a pharmaceutical firm based in the United States, received approval from the US Food and Drug Administration (FDA) in November 2023 for Zepbound (tirzepatide) injection, a novel weight loss drug. This treatment is the first of its kind to stimulate two incretin hormone receptors, GIP and GLP-1, addressing a fundamental cause of excess weight. Zepbound is prescribed to supplement a lower-calorie diet and more physical activity for long-term weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) who also have at least one weight-related health condition.

Which Companies Hold A Competitive Edge In The 1071 Market?

Major companies operating in the orlistat market are Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Roche Holding AG, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Lupin Pharmaceuticals Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Zydus Life, Emcure Pharmaceuticals Ltd., Lannett Company Inc., Strides Pharma Science Ltd., Indoco Remedies Ltd., Wockhardt Ltd., Jubilant Life Sciences Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/orlistat-global-market-report

Which Region Dominates The Orlistat Market Today?

North America was the largest region in the orlistat market in 2024. The regions covered in the orlistat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=18422&type=smp

Browse Through More Reports Similar to the Global Orlistat Market 2025, By The Business Research Company

Oral Biologics And Biosimilar Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilar-drug-global-market-report

Oral Contraceptive Pills Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Oral Thin Films Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model